BIM
MGCD

BlackRock Investment Management’s MGC Diagnostics Corporation MGCD Stock Holding History

BlackRock Investment Management’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-757
Closed -$5K – 4243
2015
Q1 		$5K Hold
757
– – ﹤0.01% 3878
2014
Q4 		$5K Hold
757
– – ﹤0.01% 3942
2014
Q3 		$5K Hold
757
– – ﹤0.01% 3912
2014
Q2 		$6K Buy
+757
New +$7.49K ﹤0.01% 3838

Other funds holding MGCD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IM
ISF Management New York $47.4M AUM 6.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

BlackRock Investment Management's MGCD Position: Q2 2015 in Review

BlackRock Investment Management sold out of MGC Diagnostics Corporation (MGCD) in Q2 2015, closing a stake of 757 shares — an estimated $5K sold.

BlackRock Investment Management first reported a position in MGCD in Q2 2014 and held it in 4 quarters. The position peaked at $6K in Q2 2014. 15 funds tracked by Wall St. Rank hold MGCD as of Q2 2015.

  • BlackRock Investment Management reported no remaining MGC Diagnostics Corporation position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 757 MGC Diagnostics Corporation shares in Q2 2015, an estimated $5K.
  • BlackRock Investment Management first reported a position in MGC Diagnostics Corporation in Q2 2014 and held it in 4 quarters.
  • BlackRock Investment Management's MGC Diagnostics Corporation position peaked at $6K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.